In our univariate analysis, stepwise inclusion of variables in the model indicated that significant prognostic factors included CEP55 protein level, lymph node metastasis, intraperitoneal metastasis, FIGO stage, differentiation grade, recurrence, age, CA153 serum level, and neoadjuvant chemotherapy. This evidence concerns the gene CEP55 and metastatic malignant neoplasm in the lymph nodes.